Ensysce Biosciences, Inc. (ENSC) Financials

$5.42

south_east
-$0.21 (-3.73%)
Day's range
$5.25
Day's range
$5.64
$10M$10M$0$0-$10M-$10M-$20M-$20M-$30M-$30MEarning201720172018201820192019202020202021202120222022202320231000%1000%500%500%0%0%-500%-500%-1000%-1000%Profit Margin
Profit Margin
Revenue
Earnings

ENSC Income statement / Annual

Last year (2023), Ensysce Biosciences, Inc.'s total revenue was $2.23 M, a decrease of 11.61% from the previous year. In 2023, Ensysce Biosciences, Inc.'s net income was -$10.61 M. See Ensysce Biosciences, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Operating Revenue $2.23 M $2.52 M $3.53 M $3.93 M $1.76 M $0.00 $0.00
Cost of Revenue $7.59 M $19.84 M $151.00 $1.37 M $3.33 M $1.56 M $0.00
Gross Profit -$5.36 M -$17.31 M $3.53 M $2.56 M -$1.56 M -$1.56 M $0.00
Gross Profit Ratio -2.4 -6.86 1 0.65 -0.89 0 0
Research and Development Expenses $7.59 M $19.84 M $4.69 M $4.39 M $3.40 M $0.00 $0.00
General & Administrative Expenses $5.36 M $6.91 M $18.71 M $1.15 M $6.93 M $0.00 $0.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 -$3.60 M $0.00 $0.00
Selling, General & Administrative Expenses $5.36 M $6.91 M $18.71 M $1.15 M $3.33 M $1.56 M $146,695.00
Other Expenses -$7.59 M -$2.52 M -$3.53 M -$3.93 M $0.00 $600,000.00 $0.00
Operating Expenses $5.36 M $24.22 M $19.87 M $1.61 M $3.33 M $959,245.00 $146,695.00
Cost And Expenses $12.95 M $24.22 M $19.87 M $1.61 M $3.33 M $959,240.00 $146,695.00
Interest Income $0.00 $1.25 M $3.22 M $719,646.00 $4.25 M $3.63 M $0.00
Interest Expense $353,945.00 $109,525.00 $1.30 M $995,496.00 $0.00 $0.00 $0.00
Depreciation & Amortization -$3.00 $151.00 $151.00 $201.00 $201.00 $161,141.00 $0.00
EBITDA -$10.72 M -$24.22 M -$19.87 M -$1.61 M $921,154.00 $2.68 M -$27,555.00
EBITDA Ratio -4.81 -9.6 -5.63 -0.41 -1.89 0 0
Operating Income Ratio -4.81 -9.6 -5.63 -0.41 -1.89 0 0
Total Other Income/Expenses Net $91,912.00 $14,410.00 -$9.28 M $1.45 M $4.25 M $3.64 M $119,142.00
Income Before Tax -$10.63 M -$24.21 M -$29.15 M -$160,875.00 $921,154.00 $2.68 M -$27,558.00
Income Before Tax Ratio -4.76 -9.59 -8.25 -0.04 0.52 0 0
Income Tax Expense $0.00 $753,876.00 -$151.00 $777,851.00 -$555,200.00 $553,916.00 $3,635.00
Net Income -$10.61 M -$24.96 M -$29.15 M -$938,726.00 $1.48 M -$1.34 M -$31,193.00
Net Income Ratio -4.76 -9.89 -8.25 -0.24 0.84 0 0
EPS -4.69 -138.73 -346.9 -14.29 15.02 -12.91 -0.3
EPS Diluted -4.69 -138.73 -346.9 -13.65 15.02 -12.91 -0.3
Weighted Average Shares Out $2.26 M $179,932.00 $84,018.00 $65,703.00 $98,262.00 $104,015.00 $105,000.00
Weighted Average Shares Out Diluted $2.26 M $179,932.00 $84,018.00 $68,780.00 $98,262.00 $104,015.00 $105,000.00
Link